| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |